|
Special Issue:
动物医学合辑Veterninary Medicine
|
|
|
|
| Alphaherpesvirus-vectored vaccines against animal diseases: Current progress |
HU Yang1, 2, 3*, WANG Ming-shu1, 2, 3*, CHENG An-chun1, 2, 3, JIA Ren-yong1, 2, 3, YANG Qiao1, 2, 3, WU Ying1, 2, 3, LIU Ma-feng1, 2, 3, ZHAO Xin-xin1, 2, 3, ZHU De-kang2, 3, CHEN Shun1, 2, 3, ZHANG Sha-qiu1, 2, 3, WANG Yin2, GAO Qun1, 2, 3, OU Xu-min1, 2, 3, MAO Sai1, 2, 3, WEN Xing-jian1, 2, 3, XU Zhi-wen2, CHEN Zheng-li2, ZHU Ling2, LUO Qi-hui2, TIAN Bin1, 3, PAN Lei-chang1, 3, Mujeeb Ur REHMAN1, 3, LIU Yun-ya1, 2, 3, YU Yan-ling1, 2, 3, ZHANG Ling1, 2, 3, CHEN Xiao-yue1, 2, 3 |
1 Institute of Preventive Veterinary Medicine, Sichuan Agricultural University, Chengdu 611130, P.R.China
2 Key Laboratory of Animal Disease and Human Health of Sichuan Province, Sichuan Agricultural University, Chengdu 611130, P.R.China
3 Avian Disease Research Center, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611130, P.R.China |
|
|
|
|
摘要
重组病毒活载体疫苗是一种能够有效激活特异性和非特异性免疫、可多联多价、安全性好的新型疫苗。动物α疱疹病毒拥有较大的基因组，含有多个不影响病毒复制的非必需区，能够插入接受外源基因并表达相应抗原蛋白；同时具有较广泛的宿主谱，能够在宿主体内复制并持续刺激动物产生对抗相应病原的免疫力，是作为重组病毒活载体疫苗的理想载体。随着基因编辑技术的发展，可通过多种方法构建能够表达外源基因的重组病毒。目前以动物α疱疹病毒为载体的重组病毒活载体疫苗研究已经涉及禽类、猪、牛、羊、伴侣动物等，目前成功构建的多株重组动物α疱疹病毒能免疫后可使动物同时获得对多种疾病的免疫。本文总结了重组动物α疱疹病毒构建方法、外源基因的引入和表达以及动物α疱疹病毒活载体疫苗免疫作用三个方面的内容，包括了最新的基因编辑技术、不同的构建策略及其优缺点、外源基因的选择、插入形式和位点等，并介绍了各种动物α疱疹病毒活载体疫苗的最新研究进展，旨在为新型动物α疱疹病毒活载体疫苗的研究和开发提供一定的参考。
Abstract Recombinant virus-vectored vaccines are novel agents that can effectively activate specific and nonspecific immunity, are multivalent and multieffective, and have high safety ratings. Animal alphaherpesviruses have a large genome, contain multiple nonessential regions that do not affect viral replication and are capable of accepting the insertion of an exogenous gene and expressing the antigen protein. Furthermore, animal alphaherpesviruses have a wide host spectrum, can replicate in the host and continuously stimulate the animal to produce immunity to the corresponding pathogen, thus making them ideal carriers for recombinant virus-vectored vaccines. With the development of gene-editing technology, recombinant viruses capable of expressing foreign genes can be constructed by various methods. Currently, studies on recombinant virus-vectored vaccines constructed based on animal alphaherpesviruses have involved poultry, pigs, cattle, sheep, and companion animals. Studies have shown that the construction of recombinant animal alphaherpesviruses enables the acquisition of immunity to multiple diseases. This article mainly summarizes the current progress on animal alphaherpesvirus-vectored vaccines, aiming to provide reference for the development of new animal alphaherpesvirus-vectored vaccines.
|
|
Received: 28 April 2019
Accepted:
|
| Fund: This work was supported by grants from the National Key Research and Development Program of China (2017YFD0500800), the earmarked fund for China Agriculture Research System (CARS-42-17), the Integration and Demonstration of Key Technologies for Goose Industrial Chain in Sichuan Province, China (2018NZ0005), and the Sichuan Veterinary Medicine and Drug Innovation Group of China Agriculture Research System (SCCXTD-2020-18). |
|
Corresponding Authors:
Correspondence CHENG An-chun, E-mail: chenganchun@vip.163.com
|
| About author: HU Yang, E-mail: hy514103978@163.com;
* These authors contributed equally to this study. |
Cite this article:
HU Yang, WANG Ming-shu, CHENG An-chun, JIA Ren-yong, YANG Qiao, WU Ying, LIU Ma-feng, ZHAO Xin-xin, ZHU De-kang, CHEN Shun, ZHANG Sha-qiu, WANG Yin, GAO Qun, OU Xu-min, MAO Sai, WEN Xing-jian, XU Zhi-wen, CHEN Zheng-li, ZHU Ling, LUO Qi-hui, TIAN Bin, PAN Lei-chang, Mujeeb Ur REHMAN, LIU Yun-ya, YU Yan-ling, ZHANG Ling, CHEN Xiao-yue.
2020.
Alphaherpesvirus-vectored vaccines against animal diseases: Current progress. Journal of Integrative Agriculture, 19(8): 1928-1940.
|
Abudayyeh O O, Gootenberg J S, Essletzbichler P, Han S, Joung J, Belanto J J. 2017. RNA targeting with CRISPR-Cas13. Nature, 550, 280–284.
Adachi S, Hori K, Hiraga S. 2006. Subcellular positioning of F plasmid mediated by dynamic localization of SopA and SopB. Journal of Molecular Biology, 356, 850–863.
Albertini A A, Ruigrok R W, Blondel D. 2011. Rabies virus transcription and replication. Advances in Virus Research, 79, 1–22.
Amorij J P, Wlj H, Frijlink H W, Wilschut J C, Huckriede A. 2010. Needle-free influenza vaccination. Lancet Infectious Diseases, 10, 699.
Archer B N, Weyer J, Paweska J, Nkosi D, Leman P, Tint K S. 2011. Outbreak of Rift Valley fever affecting veterinarians and farmers in South Africa, 2008. South African Medical Journal, 101, 263–266.
Atkins C, Freiberg A N. 2017. Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection. Future Virology, 12, 651–665.
Barrera J, Schutta C, Pisano M, Grubman M J, Brake D A, Miller T. 2018. Use of ENABL(R) adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine. Vaccine, 36, 1078–1084.
Benelli G, Buttazzoni L, Canale A, D’Andrea A, Serrone P D, Delrio G. 2017. Bluetongue outbreaks: Looking for effective control strategies against Culicoides vectors. Research in Veterinary Science, 115, 263–270.
Biswas S, Bandyopadhyay S, Dimri U, Patra P H. 2013. Bovine herpesvirus-1 (BHV-1) - A re-emerging concern in livestock: A revisit to its biology, epidemiology, diagnosis, and prophylaxis. Veterinary Quarterly, 33, 68–81.
Brune W, Messerle M, Koszinowski U H. 2000. Forward with BACs: New tools for herpesvirus genomics. Trends in Genetics Tig, 16, 254–259.
Budaszewski R D F, Messling V V. 2016. Morbillivirus experimental animal models: Measles virus pathogenesis insights from canine distemper virus. Viruses, 8, 274.
Burton E A, Wechuck J B, Wendell S K, Goins W F, Fink D J, Glorioso J C. 2001. Multiple applications for replication-defective herpes simplex virus vectors. Stem Cells, 19, 358–377.
Carter J, Wiedenheft B. 2015. SnapShot: CRISPR-RNA-Guided adaptive immune systems. Cell, 163, 260.
Chen Y, Guo W, Xu Z, Yan Q, Luo Y, Shi Q. 2011. A novel recombinant pseudorabies virus expressing parvovirus VP2 gene: Immunogenicity and protective efficacy in swine. Virology Journal, 8, 307.
Cui H, Gao H, Cui X, Zhao Y, Shi X, Li Q. 2013. Avirulent Marek’s disease virus type 1 strain 814 vectored vaccine expressing avian influenza (AI) virus H5 haemagglutinin induced better protection than turkey herpesvirus vectored AI vaccine. PLoS ONE, 8, e53340.
Davison A J, Eberle R, Ehlers B, Hayward G S, Mcgeoch D J, Minson A C, Pellett P E, Roizman B, Studdert M J, Thiry E. 2009. The order herpesvirales. Archives of Virology, 154, 171–177.
Demaula C D, Bonneau K R, Maclachlan N J. 2000. Changes in the outer capsid proteins of bluetongue virus serotype ten that abrogate neutralization by monoclonal antibodies. Virus Research, 67, 59–66.
Diallo A. 1990. Morbillivirus group: Genome organisation and proteins. Veterinary Microbiology, 23, 155–163.
Dong B, Zarlenga D S, Ren X. 2014. An overview of live attenuated recombinant pseudorabies viruses for use as novel vaccines. Journal of Immunology Research, 2014, 824630.
Duan Z, Xu H, Ji X, Zhao J. 2015. Recombinant Newcastle disease virus-vectored vaccines against human and animal infectious diseases. Future Microbiology, 10, 1307–1323.
Ehrkeschulz E, Schiwon M, Leitner T, Dávid S, Bergmann T, Liu J. 2017. CRISPR/Cas9 delivery with one single adenoviral vector devoid of all viral genes. Scientific Reports, 7, 17113.
Ewer K J, Lambe T, Rollier C S, Spencer A J, Hill A V, Dorrell L. 2016. Viral vectors as vaccine platforms: From immunogenicity to impact. Current Opinion in Immunology, 41, 47–54.
Garneau J E, Dupuis M, Villion M, Romero D A, Barrangou R, Boyaval P. 2010. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature, 468, 67–71.
Gimeno I M, Cortes A L, Faiz N M, Hernandezortiz B A, Guy J S, Hunt H D. 2015. Evaluation of the protection efficacy of a serotype 1 Marek’s disease virus-vectored bivalent vaccine against infectious laryngotracheitis and Marek’s disease. Avian Diseases, 59, 255–262.
De Groot A S, Einck L, Moise L, Chambers M, Ballantyne J, Malone R W. 2013. Making vaccines “on demand”: A potential solution for emerging pathogens and biodefense? Human Vaccines & Immunotherapeutics, 9, 1877–1884.
Gordon A. 2005. Overview of vaccines and vaccination. Molecular Biotechnology, 29, 255–271.
He T Q, Wang M S, Cao X L, Cheng A C, Wu Y, Yang Q, Liu M F, Zhu D K, Jia R Y, Chen S, Sun K F, Zhao X X, Chen X Y. 2018. Molecular characterization of duck enteritis virus UL41 protein. Virology Journal, 15, 12.
Holman D H, Pennnicholson A, Wang D H, Woraratanadharm J, Harr M K, Luo M. 2009. A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity. Clinical & Vaccine Immunology, 16, 1624–1632.
Hu X X, Wang M S, Chen S, Jia R Y, Zhu D K, Liu M. 2017. The duck enteritis virus early protein, UL13, found in both nucleus and cytoplasm, influences viral replication in cell culture. Poultry Science, 96, 2899–2907.
Huang J, Jia R Y, Wang M S, Shu B, Yu X, Zhu D K, Chen S, Yin Z, Chen X, Cheng A C. 2014. An attenuated duck plague virus (DPV) vaccine induces both systemic and mucosal immune responses to protect ducks against virulent DPV infection. Clinical and Vaccine Immunology, 21, 457–462.
Huiskonen J T, Överby A K, Weber F, Grünewald K. 2009. Electron cryo-microscopy and single-particle averaging of rift valley fever virus: Evidence for GN-GC glycoprotein heterodimers. Journal of Virology, 83, 3762–3769.
Ikeda Y, Shibata I, Xuan X, Matsumoto Y, Otsuka H. 2000. Immunogenic properties of a bovine herpesvirus-1 (BHV-1) recombinant expressing major pseudorabies virus (PrV) glycoproteins in combination. Journal of Veterinary Medical Science, 62, 849–859.
Ishino Y, Shinagawa H, Makino K, Amemura M, Nakata A. 1987. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. Journal of Bacteriology, 169, 5429–5433.
Iss K, Guedes F, Fernandes E R, Dos R S S. 2017. Immunological aspects of rabies: A literature review. Archives of Virology, 162, 1–18.
Jing Y C, Wu Y, Sun K F, Wang M S, Cheng A C, Chen S, Jia R Y, Zhu D K, Liu M F, Yang Q, Jing B, Chen X Y. 2017. Role of duck plague virus glycoprotein C in viral adsorption: Absence of specific interactions with cell surface heparan sulfate. Journal of Integrative Agriculture, 16, 1145–1152.
Johnson N, Vos A, Freuling C, Tordo N, Fooks A R, Müller T. 2010. Human rabies due to lyssavirus infection of bat origin. Veterinary Microbiology, 142, 151–159.
Jost C C, Nzietchueng S, Kihu S, Bett B, Njogu G, Swai E S. 2010. Epidemiological assessment of the Rift Valley fever outbreak in kenya and tanzania in 2006 and 2007. American Journal of Tropical Medicine & Hygiene, 83, 65–72.
Kato-Inui T, Takahashi G, Hsu S, Miyaoka Y. 2018. Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 with improved proof-reading enhances homology-directed repair. Nucleic Acids Research, 46, 4677–4688.
Kim U J, Shizuya H, Jong P J D, Birren B, Simon M I. 1992. Stable propagation of cosmid sized human DNA inserts in an F factor based vector. Nucleic Acids Research, 20, 1083–1085.
Kimurakuroda J, Yasui K. 1988. Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. Journal of Immunology, 141, 3606–3610.
Klupp B G, Hengartner C J, Mettenleiter T C, Enquist L W. 2004. Complete, annotated sequence of the pseudorabies virus genome. Journal of Virology, 78, 424–440.
Kortekaas J, de Boer S M, Kant J, Vloet R P, Antonis A F, Moormann R J. 2010. Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector. Vaccine, 28, 4394–4401.
Kyriakis C S, Billinis C, Papadopoulos E, Vasileiou N G, Athanasiou L V, Fthenakis G C. 2015. Bluetongue in small ruminants: An opinionated review, with a brief appraisal of the 2014 outbreak of the disease in Greece and the south-east Europe. Veterinary Microbiology, 181, 66–74.
Lam K N, Cheng J, Engel K, Neufeld J D, Charles T C. 2015. Current and future resources for functional metagenomics. Frontiers in Microbiology, 6, 1196.
Levings R L, Roth J A. 2013. Immunity to bovine herpesvirus 1: I. viral lifecycle and innate immunity. Animal Health Research Reviews, 14, 88–102.
Li H, Wang Y, Han Z, Wang Y, Liang S, Jiang L. 2016. Recombinant duck enteritis viruses expressing major structural proteins of the infectious bronchitis virus provide protection against infectious bronchitis in chickens. Antiviral Research, 130, 19–26.
Li K, Liu Y, Liu C, Gao L, Zhang Y, Gao Y. 2016a. Effects of different promoters on the protective efficacy of recombinant Marek’s disease virus type 1 expressing the VP2 gene of infectious bursal disease virus. Vaccine, 34, 5744–5750.
Li K, Liu Y, Liu C, Gao L, Zhang Y, Cui H. 2016b. Recombinant Marek’s disease virus type 1 provides full protection against very virulent Marek’s and infectious bursal disease viruses in chickens. Scientific Reports, 6, 39263.
Lin Y J, Wu S C. 2005. Histidine at residue 99 and the transmembrane region of the precursor membrane prM protein are important for the prM-E heterodimeric complex formation of Japanese encephalitis virus. Journal of Virology, 79, 8535–8544.
Linthicum K J, Britch S C, Anyamba A. 2016. Rift valley fever: An emerging mosquito-borne disease. Annual Review of Entomology, 61, 395–415.
Liu J, Chen P, Jiang Y, Wu L, Zeng X, Tian G. 2011. A duck enteritis virus-vectored bivalent live vaccine provides fast and complete protection against H5N1 avian influenza virus infection in ducks. Journal of Virology, 85, 10989.
Liu S Y, Jia R Y, Li Q Q, Feng D S, Shen H Y, Yang C, Wang M S, Zhu D K, Chen S, Liu M F, Zhao X X, Yin Z Q, Cheng A C. 2018. Immunogenicity and protective efficacy of DHBV DNA vaccines expressing envelope and capsid fusion proteins in ducks delivered by attenuated Salmonella typhimurium. Journal of Integrative Agriculture, 17, 928–939.
Liu T, Cheng A, Wang M, Jia R, Yang Q, Wu Y. 2017. RNA-seq comparative analysis of Peking ducks spleen gene expression 24 h post-infected with duck plague virulent or attenuated virus. Veterinary Research, 48, 47.
Liu X, Wei S, Liu Y, Fu P, Gao M, Mu X, Liu H, Xing M, Ma B, Wang J. 2013. Recombinant duck enteritis virus expressing the HA gene from goose H5 subtype avian influenza virus. Vaccine, 31, 5953–5959.
Liu Y, Li K, Cui H, Gao L, Liu C, Zhang Y. 2017. Comparison of different sites in recombinant Marek’s disease virus for the expression of green fluorescent protein. Virus Research, 235, 82–85.
Liu Y, Li K, Gao Y, Gao L, Zhong L, Zhang Y. 2016. Recombinant marek’s disease virus as a vector-based vaccine against avian leukosis virus subgroup J in chicken. Viruses, 8, 301.
Lone B A, Karna S K L, Ahmad F, Shahi N, Pokharel Y R. 2018. CRISPR/Cas9 system: A bacterial tailor for genomic engineering. Genetics Research International, 18, 3797214.
Loots A K, Mitchell E, Dalton D L, Kotzé A, Venter E H. 2017. Advances in canine distemper virus (CDV) pathogenesis research: A wildlife perspective. Journal of General Virology, 98, 311–321.
Ma G, Eschbaumer M, Said A, Hoffmann B, Beer M, Osterrieder N. 2012. An equine herpesvirus type 1 (EHV-1) expressing VP2 and VP5 of serotype 8 bluetongue virus (BTV-8) induces protection in a murine infection model. PLoS ONE, 7, e34425.
Ma Y C, Zeng Q R, Wang M S, Cheng A C, Jia R Y, Yang Q, Wu Y, Zhao X X, Liu M F, Zhu D K, Chen S, Zhang S Q, Liu Y Y, Yu Y L, Zhang L, Chen X Y. 2018. US10 protein is crucial but not indispensable for duck enteritis virus infection in vitro. Scientific Reports, 8, 16510.
Makarova K S, Haft D H, Rodolphe B, Brouns S J J, Emmanuelle C, Philippe H. 2011. Evolution and classification of the CRISPR-Cas systems. Nature Reviews Microbiology, 9, 467–477.
Marcaccini A, López P M, Quiroga M I, Bermúdez R, Nieto J M, Alemañ N. 2008. Pseudorabies virus infection in mink: A host-specific pathogenesis. Veterinary Immunology & Immunopathology, 124, 264–273.
Marston D A, Banyard A C, Mcelhinney L M, Freuling C M, Finke S, De L X. 2018. The lyssavirus host-specificity conundrum-rabies virus - the exception not the rule. Current Opinion in Virology, 28, 68–73.
Martella V, Cirone F, Elia G, Lorusso E, Decaro N, Campolo M. 2006. Heterogeneity within the hemagglutinin genes of canine distemper virus (CDV) strains detected in Italy. Veterinary Microbiology, 116, 301–309.
Martin J, Krzysztof C, Ines F, Michael H, Doudna J A, Emmanuelle C. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 337, 816–821.
Meyer C, Garzia A, Mazzola M, Gerstberger S, Molina H, Tuschl T. 2018. The TIA1 RNA-binding protein family regulates EIF2AK2-Mediated stress response and cell cycle progression. Molecular Cell, 69, 622.
Mojica V C, Soria E, Juez G. 2000. Biological significance of a family of regularly spaced repeats in the genomes of Archaea, Bacteria and mitochondria. Molecular Microbiology, 36, 244–246.
Mourad B, Fauziah M J, Firth A E, Grimes J M, Mertens P P C, Houssam A. 2011. Detection of a fourth orbivirus non-structural protein. PLoS ONE, 6, e25697.
Muyrers J P, Zhang Y, Stewart A F. 2001. Techniques: Recombinogenic engineering - new options for cloning and manipulating DNA. Trends in Biochemical Sciences, 26, 325–331.
Na F, Yu Y, Wang T, Wilker P, Wang J, Li Y. 2016. Fatal canine distemper virus infection of giant pandas in China. Scientific Reports, 6, 27518.
Otsuka H, Xuan X, Shibata I, Mori M. 1996. Protective immunity of bovine herpesvirus-1 (BHV-1) recombinants which express pseudorabies virus (PRV) glycoproteins gB, gC, gD and gE. Archives of Virology, 141, 57–71.
Pan Z, Liu J, Ma J, Jin Q, Yao H, Osterrieder K. 2017. The recombinant EHV-1 vector producing CDV hemagglutinin as potential vaccine against canine distemper. Microbial Pathogenesis, 111, 388–394.
Ping Q, Zhi X, Bo W, Zhang H, Chen H, Li X. 2015. Construction and immune efficacy of recombinant pseudorabies virus expressing PrM-E proteins of Japanese encephalitis virus genotype ?. Virology Journal, 12, 214.
Pomeranz L E, Reynolds A E, Hengartner C J. 2005. Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine. Microbiology & Molecular Biology Reviews, 69, 462–500.
Qi X F, Yang X Y, Cheng A C, Wang M S, Guo Y, Jia R Y. 2009. Replication kinetics of duck virus enteritis vaccine virus in ducklings immunized by the mucosal or systemic route using real-time quantitative PCR. Research in Veterinary Science, 86, 63–67.
Qi X F, Yang X Y, Cheng A C, Wang M S, Zhu D K, Jia R Y. 2008a. Quantitative analysis of virulent duck enteritis virus loads in experimentally infected ducklings. Avian Diseases, 52, 338–344.
Qi X F, Yang X Y, Cheng A C, Wang M S, Zhu D K, Jia R Y. 2008b. The pathogenesis of duck virus enteritis in experimentally infected ducks: A quantitative time-course study using TaqMan polymerase chain reaction. Avian Pathology, 87, 1768–1772.
Ren X G, Xue F, Zhu Y M, Tong G Z, Wang Y H, Feng J K. 2009. Construction of a recombinant BHV-1 expressing the VP1 gene of foot and mouth disease virus and its immunogenicity in a rabbit model. Biotechnology Letters, 31, 1159–1165.
Roy P. 2017. Bluetongue virus structure and assembly. Current Opinion in Virology, 24, 115–123.
Rudolph J, O’Callaghan D J, Osterrieder N. 2002. Cloning of the genomes of equine herpesvirus type 1 (EHV-1) strains KyA and racL11 as bacterial artificial chromosomes (BAC). Journal of Veterinary Medicine (Series B), 49, 31–36.
Said A, Elmanzalawy M, Ma G, Damiani A M, Osterrieder N. 2017. An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep. Virology Journal, 14, 154.
Said A, Lange E, Beer M, Damiani A, Osterrieder N. 2013. Recombinant equine herpesvirus 1 (EHV-1) vaccine protects pigs against challenge with influenza A (H1N1)pmd09. Virus Research, 173, 371–376.
Schmid-Burgk J L. 2017. Disruptive non-disruptive applications of CRISPR/Cas9. Current Opinion in Biotechnology, 48, 203–209.
Schwartzcornil I, Mertens P P, Contreras V, Hemati B, Pascale F, Bréard E. 2008. Bluetongue virus: Virology, pathogenesis and immunity. Veterinary Research, 39, 46.
Shen F X, Ma G P, Cheng A C, Wang M S, Li C F, Sun K F, Chang H, Zhu D K, Jia R Y, Chen X Y, Sun T. 2010. Development and application of an indirect immunohistochemical method for the detection of duck plague virus vaccine antigens in paraffin sections and localization in the vaccinated duckling tissues. Poultry Science, 89, 1915–1923.
Shizuya H, Birren B, Kim U J, Mancino V, Slepak T, Tachiiri Y. 1992. Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector. Proceedings of the National Academy of Sciences of the United States of America, 89, 8794–8797.
Singh R, Singh K P, Cherian S, Saminathan M, Kapoor S, Manjunatha Reddy G B. 2017. Rabies - Epidemiology, pathogenesis, public health concerns and advances in diagnosis and control: A comprehensive review. Veterinary Quarterly, 37, 212–251.
Song J, Dong H, Ma C, Zhao B, Shang G. 2010. Construction and functional characterization of an integrative form lambda Red recombineering Escherichia coli strain. Fems Microbiology Letters, 309, 178–183.
Souza A P, Haut L, Reyessandoval A, Pinto A R. 2005. Recombinant viruses as vaccines against viral diseases. Brazilian Journal of Medical & Biological Research, 38, 509–522.
Sow A, Faye O, Ba Y, Ba H, Diallo D, Faye O. 2014. Rift Valley fever outbreak, southern Mauritania, 2012. Emerging Infectious Diseases, 20, 296–299.
Suzuki J, Nishio Y, Kameo Y, Terada Y, Kuwata R, Shimoda H. 2015. Canine distemper virus infection among wildlife before and after the epidemic. Journal of Veterinary Medical Science, 77,1457–1463.
Tischer B K, Kaufer B B. 2012. Viral bacterial artificial chromosomes: Generation, mutagenesis, and removal of mini-F sequences. Journal of Biomedicine & Biotechnology, 2012, 472537.
Tischer B K, Smith G A, Osterrieder N. 2010. En Passant mutagenesis: A two step markerless red recombination system. In: Braman J, eds., In Vitro Mutagenesis Protocols. Methods in Molecular Biology (Methods and Protocols), vol. 634. Humana Press, Totowa, NJ.
Veerapen V P, Van A Z, Wigdorovitz A, Rybicki E P, Meyers A E. 2017. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana. Virus Research, 244, 213–217.
Velasco-Villa A, Mauldin M R, Shi M, Escobar L E, Gallardo-Romero N F, Damon I. 2017. The history of rabies in the Western Hemisphere. Antiviral Research, 146, 221–232.
Wagner M, Ruzsics Z, Koszinowski U H. 2002. Herpesvirus genetics has come of age. Trends in Microbiology, 10, 318–324.
Wang T, Palese P. 2009. Unraveling the mystery of swine influenza virus, Cell, 137, 983–985.
Wang Y, Yuan J, Cong X, Qin H Y, Wang C H, Li Y. 2015. Generation and efficacy evaluation of a recombinant pseudorabies virus variant expressing the E2 protein of classical swine fever virus in pigs. Clinical & Vaccine Immunology, 22, 1121–1129.
Westenberg M, Bamps S, Soedling H, Hope I A, Dolphin C T. 2010. Escherichia coli MW005: lambda red-mediated recombineering and copy-number induction of oriV-equipped constructs in a single host. BMC Biotechnology, 10, 27.
Wo?niakowski G, Samoreksalamonowicz E. 2015. Animal herpesviruses and their zoonotic potential for cross-species infection. Annals of Agricultural & Environmental Medicine (Aaem), 22, 191–194.
Wu X, Jia R, Zhou J, Wang M, Chen S, Liu M, Zhu D, Zhao X, Sun K, Yang Q, Wu Y, Yin Z, Chen X, Wang J, Cheng A. 2018. Virulent duck enteritis virus infected DEF cells generate a unique pattern of viral microRNAs and a novel set of host microRNAs. BMC Veterinary Research, 14, 144.
Wu X, Smith T G, Rupprecht C E. 2011. From brain passage to cell adaptation: The road of human rabies vaccine development. Expert Review of Vaccines, 10, 1597–1608.
Wu Y, Cheng A C, Wang M S, Yang Q, Zhu D K, Jia R Y. 2012a. Complete genomic sequence of Chinese virulent duck enteritis virus. Journal of Virology, 86, 5965.
Wu Y, Cheng A C, Wang M S, Zhu D K, Jia R Y, Chen S. 2012b. Comparative genomic analysis of duck enteritis virus strains. Journal of Virology, 86, 13841–13842.
Wu Y, Li Y G, Wang M S, Sun K F, Jia R Y, Chen S. 2017. Preliminary study of the UL55 gene based on infectious Chinese virulent duck enteritis virus bacterial artificial chromosome clone. Virology Journal, 14, 78.
Yang C, Xu Y, Jia R Y, Liu S Y, Wang M S, Zhu D K, Chen S, Liu M F, Zhao X X, Sun K F, Jing B, Yin Z Q, Cheng A C. 2017. The codon-optimized capsid gene of duck circovirus can be highly expressed in yeast and self-assemble into virus-like particles. Journal of Integrative Agriculture, 16, 1601–1608.
Yang L J, Wang M S, Zeng C H, Shi Y, Cheng A C, Liu M F, Zhu D K, Chen S, Jia R Y, Yang Q, Wu Y, Zhang S Q, Zhao X X, Huang J, Liu Y Y, Ou X M, Mao S, Yu Y L, Zhang L, Tian B, et al. 2020. Duck enteritis virus UL21 is a late gene and encodes a protein that interacts with pUL16. BMC Veterinary Research, 16, 8.
Yang Q Y, Sun Z, Tan F F, Guo L H, Wang Y Z, Wang J. 2016. Pathogenicity of a currently circulating Chinese variant pseudorabies virus in pigs. World Journal of Virology, 5, 23–30.
Yang X, Qi X F, Cheng A C, Wang M S, Zhu D K, Jia R Y. 2010. Intestinal mucosal immune response in ducklings following oral immunisation with an attenuated Duck enteritis virus vaccine. Veterinary Journal, 185, 199–203.
You Y, Liu T, Wang M S, Cheng A C, Jia R Y, Yang Q, Wu Y, Zhu D K, Chen S, Liu M F, Zhao X X, Zhang S Q, Liu Y Y, Yu Y L, Zhang L. 2018. Duck plague virus Glycoprotein J is functional but slightly impaired in viral replication and cell-to-cell spread. Scientific Reports, 8, 6488.
Yu X, Zhou Z, Hu D, Zhang Q, Han T, Li X. 2014. Pathogenic pseudorabies virus, China, 2012. Emerging Infectious Diseases, 20, 102–104.
Yuan G P, Cheng A C, Wang M S, Liu F, Han X Y, Liao Y H, Xu C. 2005. Electron microscopic studies of the morphogenesis of duck enteritis virus. Avian Diseases, 49, 50–55.
Yuan Z, Zhang S, Liu Y, Zhang F, Fooks A R, Li Q. 2008. A recombinant pseudorabies virus expressing rabies virus glycoprotein: Safety and immunogenicity in dogs. Vaccine, 26, 1314–1321.
Zhang X, Wu Y, Huang Y, Liu X. 2012. Protection conferred by a recombinant Marek’s disease virus that expresses the spike protein from infectious bronchitis virus in specific pathogen-free chicken. Virology Journal, 9, 85.
Zhang Z, Chen W, Ma C, Zhao P, Duan L, Zhang F. 2014a. Construction of recombinant Marek’s disease virus (MDV) lacking the meq oncogene and co-expressing AIV-H9N2 HA and NA genes under control of exogenous promoters. Journal of Biotechnology, 181, 45–54.
Zhang Z, Ma C, Zhao P, Duan L, Chen W, Zhang F. 2014b. Construction of recombinant Marek’s disease virus (rMDV) co-expressing AIV-H9N2-NA and NDV-F genes under control of MDV’s own bi-directional promoter. PLoS ONE, 9, e90677.
Zhao C K, He T Q, Xu Y, Wang M S, Cheng A C, Zhao X X, Zhu D K, Chen S, Liu M F, Yang Q, Jia R Y, Chen X Y, Wu Y, Zhang S Q, Liu Y Y, Yu Y L, Zhang L. 2019. Molecular characterization and antiapoptotic function analysis of the duck plague virus Us5 gene. Scientific Reports, 9, 4851.
Zheng L L, Guo X Q, Zhu Q L, Chao A J, Fu P F, Wei Z Y. 2015. Construction and immunogenicity of a recombinant pseudorabies virus co-expressing porcine circovirus type 2 capsid protein and interleukin 18. Virus Research, 201, 8–15.
Zhong Z, Huang K, Wei Y, Chen H, Liu Z, Jin M. 2017. Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection. Scientific Reports, 7, 1478.
Zhou Z W, Cao G H, Li Z, Han X J, Li C, Lu Z Y, Zhao Y H, Li X L. 2019. Truncated gRNA reduces CRISPR/Cas9-mediated off-target rate for MSTN gene knockout in bovines. Journal of Integrative Agriculture, 18, 2835–2843.
Zhu S, Guo C. 2016. Rabies control and treatment: From prophylaxis to strategies with curative potential. Viruses, 8, 279.
Zou Z, Hu Y, Liu Z, Zhong W, Cao H, Chen H. 2015. Efficient strategy for constructing duck enteritis virus-based live attenuated vaccine against homologous and heterologous H5N1 avian influenza virus and duck enteritis virus infection. Veterinary Research, 46, 1–15.
Zou Z, Ma J, Huang K, Chen H, Liu Z, Jin M. 2016. Live attenuated vaccine based on duck enteritis virus against duck hepatitis a virus types 1 and 3. Frontiers in Microbiology, 7, 1613.
Zühlsdorf M, Hinrichs W. 2017. Assemblins as maturational proteases in herpesviruses. Journal of General Virology, 98, 1969–1984.
|
| No Suggested Reading articles found! |
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
